Search research articles
Contact Us
Filters
Showing results (1-10 of 58) with videos related to
Page
of 6
Sort By:
Nihon Rinsho. Japanese Journal of Clinical Medicine
|
November 22, 2011
[New antivirals against hepatitis C virus(protease inhibitors, polymerase inhibitors, and host factor targeting antivirals)]
Naoya Kato, Ryosuke Muroyama
Nihon Rinsho. Japanese Journal of Clinical Medicine
|
March 22, 2013
[Viral hepatitis]
Naoya Kato, Ryosuke Muroyama, Kaku Goto
Nihon Rinsho. Japanese Journal of Clinical Medicine
|
May 10, 2012
[New antivirals against hepatitis C virus]
Naoya Kato, Ryosuke Muroyama, Kaku Goto
Nihon Rinsho. Japanese Journal of Clinical Medicine
|
March 14, 2015
[Hepatitis C virus induced hepatocellular carcinoma associated genes]
Naoya Kato, Ryosuke Muroyama, Kaku Goto
Nihon Rinsho. Japanese Journal of Clinical Medicine
|
February 6, 2016
[Development status of DAA against hepatitis C]
Naoya Kato, Ryo Nakagawa, Kaku Goto, et al.
Cancer Science
|
February 24, 2010
Characteristic mutations in hepatitis C virus core gene related to the occurrence of hepatocellular carcinoma
Zhongjie Hu, Ryosuke Muroyama, Norie Kowatari, et al.
Plos One
|
May 6, 2015
The characteristic changes in hepatitis B virus x region for hepatocellular carcinoma: a comprehensive analysis based on global data
Wenwen Li, Kaku Goto, Yasuo Matsubara, et al.
Virus Research
|
April 17, 2022
Fusion HBx from HBV integrant affects hepatocarcinogenesis through deregulation of ER stress response
Ryosuke Muroyama, Ryo Nakagawa, Yasuo Matsubara, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
August 18, 2006
MDM2 promoter SNP309 is associated with the risk of hepatocellular carcinoma in patients with chronic hepatitis C
Narayan Dharel, Naoya Kato, Ryosuke Muroyama, et al.
Virology
|
August 6, 2014
The flavonoid apigenin inhibits hepatitis C virus replication by decreasing mature microRNA122 levels
Chikako Shibata, Motoko Ohno, Motoyuki Otsuka, et al.
Page
of 6
Search research articles
Search
Showing results (1-10 of 58) with videos related to
Sort By:
Page
of 6
Nihon Rinsho. Japanese Journal of Clinical Medicine
|
November 22, 2011
[New antivirals against hepatitis C virus(protease inhibitors, polymerase inhibitors, and host factor targeting antivirals)]
Naoya Kato, Ryosuke Muroyama
Nihon Rinsho. Japanese Journal of Clinical Medicine
|
March 22, 2013
[Viral hepatitis]
Naoya Kato, Ryosuke Muroyama, Kaku Goto
Nihon Rinsho. Japanese Journal of Clinical Medicine
|
May 10, 2012
[New antivirals against hepatitis C virus]
Naoya Kato, Ryosuke Muroyama, Kaku Goto
Nihon Rinsho. Japanese Journal of Clinical Medicine
|
March 14, 2015
[Hepatitis C virus induced hepatocellular carcinoma associated genes]
Naoya Kato, Ryosuke Muroyama, Kaku Goto
Nihon Rinsho. Japanese Journal of Clinical Medicine
|
February 6, 2016
[Development status of DAA against hepatitis C]
Naoya Kato, Ryo Nakagawa, Kaku Goto, et al.
Cancer Science
|
February 24, 2010
Characteristic mutations in hepatitis C virus core gene related to the occurrence of hepatocellular carcinoma
Zhongjie Hu, Ryosuke Muroyama, Norie Kowatari, et al.
Plos One
|
May 6, 2015
The characteristic changes in hepatitis B virus x region for hepatocellular carcinoma: a comprehensive analysis based on global data
Wenwen Li, Kaku Goto, Yasuo Matsubara, et al.
Virus Research
|
April 17, 2022
Fusion HBx from HBV integrant affects hepatocarcinogenesis through deregulation of ER stress response
Ryosuke Muroyama, Ryo Nakagawa, Yasuo Matsubara, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
August 18, 2006
MDM2 promoter SNP309 is associated with the risk of hepatocellular carcinoma in patients with chronic hepatitis C
Narayan Dharel, Naoya Kato, Ryosuke Muroyama, et al.
Virology
|
August 6, 2014
The flavonoid apigenin inhibits hepatitis C virus replication by decreasing mature microRNA122 levels
Chikako Shibata, Motoko Ohno, Motoyuki Otsuka, et al.
Page
of 6